Sample size derivation for composite binary endpoints

07/03/2018
by   Marta Bofill Roig, et al.
0

Composite binary endpoints are increasingly used as primary endpoints in clinical trials. When designing a trial, it is crucial to determine the appropriate sample size for testing the statistical differences between treatment groups for the primary endpoint. As shown in this work, when using a composite binary endpoint to size a trial, one needs to specify the event rates and the effect sizes of the composite components as well as the correlation between them. In practice, the marginal parameters of the components can be obtained from previous studies or pilot trials, however, the correlation is often not previously reported and thus usually unknown. We first show that the sample size for composite binary endpoints is strongly dependent on the correlation and, second, that slight deviations in the prior information on the marginal parameters may result in underpowered trials for achieving the study objectives at a pre-specified significance level. We propose a general strategy for calculating the required sample size when the correlation is not specified, and accounting for uncertainty in the marginal parameter values. We present the web platform CompARE to characterize composite endpoints and to calculate the sample size just as we propose in this paper. We evaluate the performance of the proposal with a simulation study, and illustrate it by means of a real case study using CompARE.

READ FULL TEXT

page 1

page 2

page 3

page 10

page 11

page 15

page 16

page 17

research
06/20/2022

Adaptive clinical trial designs with blinded selection of binary composite endpoints and sample size reassessment

For randomized clinical trials where a single, primary, binary endpoint ...
research
12/11/2019

Sample Size Estimation using a Latent Variable Model for Mixed Outcome Co-Primary, Multiple Primary and Composite Endpoints

Mixed outcome endpoints that combine multiple continuous and discrete co...
research
08/15/2019

A hypothesis test of feasibility for external pilot trials assessing recruitment, follow-up and adherence rates

The power of a large clinical trial can be adversely affected by low rec...
research
07/25/2019

Non-constant hazard ratios in randomized controlled trials with composite endpoints

The hazard ratio is routinely used as a summary measure to assess the tr...
research
11/28/2022

Utilizing Win Ratio Approaches and Two-Stage Enrichment Designs for Small-Sized Clinical Trials

Conventional methods for analyzing composite endpoints in clinical trial...
research
11/04/2022

Design of Trials with Composite Endpoints with the R Package CompAREdesign

Composite endpoints are widely used as primary endpoints in clinical tri...

Please sign up or login with your details

Forgot password? Click here to reset